Skip to main content
. 2022 Jul 28;9:946361. doi: 10.3389/fnut.2022.946361

TABLE 3.

Main characteristics of the included randomized controlled trials.

References Country Population Duration Intervention Placebo group Dietary MeDi score Baseline age Subjects (N) Loss Outcome method Results
Hardman et al. (62) Australia Healthy older adults 0.5 years The diet group received a collection of recipes in keeping with MeDi diet style, and with the assistance of dietary consultants from Health Care 2 Maintenance of their current lifestyle FFQ 0–9 EG: 77.68 ± 7.38
CG: 78.22 ± 5.81
EG: 18
CG: 25
EG: 28%
CG: 7%
SUCCAB The MeDi diet has the potential to improve aspects of cognition in aging population
Knight et al. (63) Australia Healthy older adults 0.5 years Participants were closely monitored on a fortnightly basis in an informed meeting that followed MeDi diet food pyramids Participants were asked to simply maintain their customary lifestyle and dietary pattern FFQ 0–9 EG: 72.1 ± 4.9
CG: 72.0 ± 5.0
EG: 70
CG: 67
EG: 19%
CG: 17%
A comprehensive battery of 11 cognitive tests There was no beneficial effect of the MeDi diet intervention on cognitive function among healthy older adults
Martinez-Lapiscina et al. (64) Spain Cognitively normal participants at high CVD risk 6.5 years Participants received intensive education and advice to increase adherence to MeDi diet. Participants received free allotments of either EVOO (1 L/week) or 30 g/day of raw, unprocessed mixed nuts (15 g walnuts, 7.5 g almonds and 7.5 g hazelnuts) Participants received intensive education and advice to increase adherence to the low-fat diet and received advice to reduce all types of fat and non-food gifts as an incentive to improve compliance FFQ 0–14 All: 67.38 ± 5.65 EGE: 224
EGN: 166
CG: 132
EGE: 36%
EGN: 53%
CG: 63%
MMSE, CDT An intervention with the MeDi diet enhanced with either EVOO or nuts appears to improve cognition compared with a low-fat diet
Sanchez-Villegas et al. (65) Spain Cognitively normal participants at high CVD risk 3 years The groups assigned to MeDi diet were advised to use extra virgin olive oil for cooking. Each participant had a personal interview with a trained dietician and a group session conducted by the same dietician every 3 months during these 4 years Participants were advised to reduce all types of fat and were given recommendations according to the American guidelines FFQ 0–14 EGE: 68.1 ± 6.1
EGN: 67.4 ± 5.7
CG: 68.0 ± 6.1
EGE: 91
EGN: 75
CG: 77
/ ELISA kit Adherence to the MeDi diet was associated to an improvement in plasma BDNF concentrations in individuals with depression and to prevent depression and cognitive decline
Valls-Pedret et al. (66) Spain Cognitively normal participants at high CVD risk 4.1 years Participants were educated on how to follow the MeDi diet and received supplemental foods at no cost. Participants received free allotments of either EVOO (1 L/week) or 30 g/day of raw, unprocessed mixed nuts (15 g walnuts, 7.5 g almonds and 7.5 g hazelnuts) Participants were advised to reduce all dietary fat FFQ 0–14 EGE: 67.9 ± 5.4
EGN: 66.7 ± 5.3
CG: 65.5 ± 5.8
EGE: 127
EGN: 112
CG: 95
EGE: 18%
EGN: 24%
CG: 34%
MMSE, RAVLT, subtest of Wechsler memory scale, animal fluency test, Wechsler adult intelligence scale, CTT The MeDi diet supplemented with olive oil or nuts was associated with improved cognitive function

MeDi diet, Mediterranean diet; SUCCAB, Swinburne university computerized cognitive assessment battery; CDT, Clock drawing test; MMSE, Mini-Mental State Examination; EVOO, Extra virgin olive oil; EG, Experiment group; CG, Control group; EGE, Mediterranean diet plus Extra virgin olive oil; EGN, Mediterranean diet plus nuts; BDNF, Brain-derived neurotrophic factor; RAVLT, Rey Auditory Verbal Learning Test; CTT, Color trail test.